State AK
Clinical Trials in Alaska
Recruiting clinical trials with at least one study location in Alaska. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alaska
Anatomic Stage IV Breast Cancer AJCC v8 (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)Early Stage Triple-Negative Breast Carcinoma (1)Follicular Lymphoma (1)Previously Treated Non-Small Cell Lung Cancer (1)Untreated Follicular Lymphoma (1)Pleural Biphasic Mesothelioma (1)Pleural Sarcomatoid Mesothelioma (1)Advanced Malignant Solid Neoplasm (1)
Frequently Asked Questions — Clinical Trials in Alaska
How many clinical trials are currently recruiting in Alaska?
ClinicalMetric currently tracks 21 actively recruiting clinical trials with at least one location in Alaska. The total number of registered studies—including active but not currently enrolling trials—is 21. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alaska?
Alaska hosts clinical trials across a broad range of medical conditions, including Anatomic Stage IV Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alaska serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alaska?
To join a clinical trial in Alaska, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alaska maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alaska
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06911502 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Ri...
Condition
Follicular Lymphoma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Celgene
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06549595 Phase 3
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicul...
Condition
Untreated Follicular Lymphoma
Enrollment
1,018 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06712316 Phase 2, Phase 3
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherap...
Condition
Non-small Cell Lung Cancer
Enrollment
1,260 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
NCT06793215 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus...
Condition
Non-Small Cell Lung Cancer
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07144280 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Do...
Condition
Non-small Cell Carcinoma
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06629610 N/A
Recruiting
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Condition
Heart Disease
Enrollment
368 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT04353960 N/A
Recruiting
The Alaska Oculocardiac Reflex Study
Condition
Bradycardia
Enrollment
4,000 pts
Location
United States
Sponsor
Alaska Blind Child Discovery
NCT07063745 Phase 2, Phase 3
Recruiting
A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemothe...
Condition
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Enrollment
590 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT06459180 Phase 3
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatmen...
Condition
Cervical Cancer
Enrollment
686 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07108660 N/A
Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Inf...
Condition
Central Line Associated Blood Stream Infections (CLABSI)
Enrollment
17,800 pts
Location
United States
Sponsor
Swedish Medical Center
NCT04242095 N/A
Recruiting
Collection of Research Data and Samples From Patients Who Experience Immunothera...
Condition
Malignancy
Enrollment
240 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07214779 Phase 3
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Par...
Condition
Ovarian Cancer
Enrollment
466 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT02960022 Phase 2
Recruiting
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enza...
Condition
Prostate Cancer
Enrollment
900 pts
Location
United States, Argentina, Australia
Sponsor
Astellas Pharma Global Develop
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology